相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis
Boan Li et al.
FOOD & FUNCTION (2021)
PXR: a center of transcriptional regulation in cancer
Yaqi Xing et al.
ACTA PHARMACEUTICA SINICA B (2020)
Nuclear receptors are the major targets of endocrine disrupting chemicals
Lucia Toporova et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification
Michele A. La Merrill et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
The influence of polyphenols on metabolic disorders caused by compounds released from plastics - Review
Wojciech Zwierello et al.
CHEMOSPHERE (2020)
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
Xiao Liu et al.
GASTROENTEROLOGY (2020)
Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis
Sushweta Mahalanobish et al.
PHARMACOLOGICAL RESEARCH (2020)
MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro
Santosh K. Yadav et al.
CELL DEATH & DISEASE (2020)
Periplaneta americanaExtracts Accelerate Liver Regenerationviaa Complex Network of Pathways
Yingying Zou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Endocrine-disrupting chemicals: implications for human health
Linda G Kahn et al.
Lancet Diabetes & Endocrinology (2020)
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma
Zejia Yang et al.
CELL DEATH DISCOVERY (2020)
Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib
Chunzhan Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents
Yan Ma et al.
PHARMACOLOGICAL RESEARCH (2020)
FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
Hua Yang et al.
CELL DEATH & DISEASE (2020)
Schwann Cell Stimulation of Pancreatic Cancer Cells: A Proteomic Analysis
Aysha Ferdoushi et al.
FRONTIERS IN ONCOLOGY (2020)
Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition
Hyo-Jin Kim et al.
PHARMACOLOGICAL RESEARCH (2020)
ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors
Irem Yalim-Camci et al.
MOLECULAR CARCINOGENESIS (2019)
Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice
Xue Yuan et al.
PHARMACOLOGICAL RESEARCH (2019)
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
Zejia Yang et al.
BMC CANCER (2019)
Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo
Ling Wei et al.
PHARMACOLOGICAL RESEARCH (2019)
Functional profiling of bisphenols for nuclear receptors
Marina Grimaldi et al.
TOXICOLOGY (2019)
Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor
Sheeraz Un Nazir et al.
GENE (2019)
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
Yunhao Chen et al.
MOLECULAR CANCER (2019)
Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors
Xiaohui Liu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib
Leisheng Wang et al.
ONCOTARGETS AND THERAPY (2019)
SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity
Fan Yin et al.
CELL DEATH & DISEASE (2019)
TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR
Ella Bhagyaraj et al.
CELL CYCLE (2019)
Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo
Hong-Yuan Lu et al.
PHARMACOLOGICAL RESEARCH (2019)
MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
Bin Yang et al.
CELL DEATH & DISEASE (2019)
Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α
Lin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells
Du Meng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
A Review of Biomonitoring of Phthalate Exposures
Yu Wang et al.
TOXICS (2019)
Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Fan Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Ling Li et al.
CANCER CELL (2018)
Inhibition of UDP-glucuronosyltransferases (UGTs) by phthalate monoesters
Zuo Du et al.
CHEMOSPHERE (2018)
The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
Bryan Mackowiak et al.
DRUG METABOLISM AND DISPOSITION (2018)
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting
Maria Elisabeth Street et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Parabens and their effects on the endocrine system
Karolina Nowak et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
Fan Feng et al.
PHARMACOLOGICAL RESEARCH (2018)
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
Yingshi Zhang et al.
CELL DEATH & DISEASE (2018)
Transcriptomic responses of Nile tilapia (Oreochromis niloticus) liver to environmental concentration of di(2-ethylhexyl)phthalate
Linbao Zhang et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2018)
ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR
Zhiyi Shao et al.
PHARMACOLOGICAL RESEARCH (2018)
MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor
Jiaqi Li et al.
ONCOTARGETS AND THERAPY (2018)
Early-life exposure to EDCs: role in childhood obesity and neurodevelopment
Joseph M. Braun
NATURE REVIEWS ENDOCRINOLOGY (2017)
PXR: More Than Just a Master Xenobiotic Receptor
Peter O. Oladimeji et al.
MOLECULAR PHARMACOLOGY (2017)
Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells
Hui Ren et al.
ONCOTARGET (2017)
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Endocrine-Disrupting Chemicals
Andrea C. Gore
JAMA INTERNAL MEDICINE (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Estrogen receptor a enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner
Peng Cao et al.
BMC CANCER (2015)
A comparative study on antioxidant status combined with integrated biomarker response in Carassius auratus fish exposed to nine phthalates
Ruijuan Qu et al.
ENVIRONMENTAL TOXICOLOGY (2015)
Role of pregnane X receptor in chemotherapeutic treatment
Wei Zhuo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Comparative antioxidant responses in liver of Carassius auratus exposed to phthalates: An integrated biomarker approach
Qing Zheng et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2013)
Effects of MAPK Signaling on 1,25-Dihydroxyvitamin D-Mediated CYP24 Gene Expression in the Enterocyte-Like Cell Line, Caco-2
Min Cui et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer
E Myers et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of rat cytochrome P450C24 (CYP24) gene expression -: Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D3-mediated induction
PP Dwivedi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
